NEKTAR THERAPEUTICS

NKTR · Nasdaq · SIC 2834: Pharmaceutical Preparations
231
SEC Filings

Business Summary

Nektar Therapeutics (Nektar, we) is a clinical stage, research-based drug discovery biopharmaceutical company focused on discovering and developing innovative medicines in the field of immunotherapy. Within this growing field, we direct our efforts toward creating new immunomodulatory agents that selectively induce, amplify, attenuate or prevent immune responses in order to achieve desired therapeutic outcomes. We apply our deep understanding of immunology to identify and create innovative drug ...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNKTRdiscussed_in_filing Cybersecurity
topic_mentionNKTRdiscussed_in_filing Cybersecurity
topic_mentionNKTRdiscussed_in_filing Healthcare & Bio
topic_mentionNKTRdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001193125-26-104547EDGAR74K words
2025-03-142024-12-310000950170-25-039389EDGAR—
2024-03-052023-12-310000950170-24-026249EDGAR—
2023-02-282022-12-310000906709-23-000004EDGAR—
2022-03-012021-12-310000906709-22-000005EDGAR—
2021-02-262020-12-310000906709-21-000005EDGAR—
2020-02-282019-12-310000906709-20-000004EDGAR—
2019-03-012018-12-310001564590-19-005639EDGAR—
2018-03-012017-12-310001564590-18-004105EDGAR—
2017-03-012016-12-310001564590-17-003064EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001193125-25-270230EDGAR45K words
2025-08-082025-06-300000950170-25-105275EDGAR—
2025-05-092025-03-310000950170-25-067279EDGAR—
2024-11-082024-09-300000950170-24-123570EDGAR—
2024-08-092024-06-300000950170-24-094231EDGAR—
2024-05-102024-03-310000950170-24-057312EDGAR—
2023-11-082023-09-300000950170-23-060475EDGAR—
2023-08-092023-06-300000906709-23-000012EDGAR—
2023-05-102023-03-310000906709-23-000008EDGAR—
2022-11-042022-09-300000906709-22-000019EDGAR—
2022-08-052022-06-300000906709-22-000014EDGAR—
2022-05-062022-03-310000906709-22-000010EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001213900-26-027026EDGAR4K words
2026-02-130001193125-26-049378EDGAR—
2026-02-100001193125-26-044751EDGAR—
2026-02-100001193125-26-043755EDGAR—
2026-01-270001213900-26-008210EDGAR—
2025-12-160001193125-25-320009EDGAR—
2025-11-210001213900-25-113606EDGAR—
2025-11-100001213900-25-107821EDGAR—
2025-11-060001213900-25-107180EDGAR—
2025-09-180001213900-25-088792EDGAR—

231 total filings indexed. 199 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000906709
TickerNKTR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bd004e2593dd5b5c56bee953b24cf6739b736c606d8b9f4af0d3942e4cbc2798
parent: 2cdfce9337c3e86d39764c0d3377779ab87347ae08ee60e820869c9e878c7978
content hash: 0e325dc80215576d9939343fd36cf982be0c75c20412e1954a2105cc313706bf
signed: 2026-04-13T04:46:31.289Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf